Bank of America
SRNE

Bank of America’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bank of America’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,987,772
Closed -$2.65M – 8601
2022
Q4 		$2.65M Buy
2,987,772
+1,167,813
+64% +$1.55M ﹤0.01% 3998
2022
Q3 		$2.86M Buy
1,819,959
+430,967
+31% +$978K ﹤0.01% 3954
2022
Q2 		$2.79M Buy
1,388,992
+95,156
+7% +$165K ﹤0.01% 3989
2022
Q1 		$3.01M Buy
1,293,836
+1,076,786
+496% +$3.36M ﹤0.01% 4171
2021
Q4 		$1.01M Sell
217,050
-60,763
-22% -$377K ﹤0.01% 5235
2021
Q3 		$2.12M Buy
277,813
+4,451
+2% +$37.7K ﹤0.01% 4382
2021
Q2 		$2.65M Sell
273,362
-147,820
-35% -$1.18M ﹤0.01% 4085
2021
Q1 		$3.48M Buy
421,182
+130,922
+45% +$1.38M ﹤0.01% 3754
2020
Q4 		$1.98M Sell
290,260
-19,776
-6% -$159K ﹤0.01% 3959
2020
Q3 		$3.46M Sell
310,036
-64,939
-17% -$594K ﹤0.01% 3256
2020
Q2 		$2.35M Buy
374,975
+166,574
+80% +$638K ﹤0.01% 3489
2020
Q1 		$384K Buy
208,401
+24,852
+14% +$71.6K ﹤0.01% 4697
2019
Q4 		$620K Sell
183,549
-38,592
-17% -$92K ﹤0.01% 4861
2019
Q3 		$476K Buy
222,141
+1,297
+0.6% +$3.02K ﹤0.01% 5120
2019
Q2 		$590K Buy
220,844
+24,954
+13% +$89.8K ﹤0.01% 4944
2019
Q1 		$931K Buy
195,890
+32,047
+20% +$84.1K ﹤0.01% 4571
2018
Q4 		$393K Sell
163,843
-432
-0.3% -$1.41K ﹤0.01% 5092
2018
Q3 		$723K Sell
164,275
-278,357
-63% -$1.54M ﹤0.01% 4708
2018
Q2 		$3.19M Buy
442,632
+279,677
+172% +$1.9M ﹤0.01% 3586
2018
Q1 		$839K Buy
162,955
+17,531
+12% +$125K ﹤0.01% 4509
2017
Q4 		$553K Buy
145,424
+1,000
+0.7% +$2.6K ﹤0.01% 4885
2017
Q3 		$246K Sell
144,424
-8,314
-5% -$15.3K ﹤0.01% 5288
2017
Q2 		$306K Buy
152,738
+559
+0.4% +$1.09K ﹤0.01% 5122
2017
Q1 		$601K Buy
152,179
+3,057
+2% +$15.3K ﹤0.01% 4770
2016
Q4 		$731K Buy
149,122
+147,821
+11,362% +$888K ﹤0.01% 4558
2016
Q3 		$10K Buy
1,301
+699
+116% +$4.71K ﹤0.01% 6404
2016
Q2 		$3K Buy
+602
New +$3.85K ﹤0.01% 6836
2016
Q1 		– Sell
-686
Closed -$6K – 7429
2015
Q4 		$6K Sell
686
-378,175
-100% -$3.19M ﹤0.01% 6843
2015
Q3 		$3.18M Buy
378,861
+369,684
+4,028% +$5.89M ﹤0.01% 3323
2015
Q2 		$162K Sell
9,177
-6,314
-41% -$81.1K ﹤0.01% 5350
2015
Q1 		$179K Buy
15,491
+7,091
+84% +$82K ﹤0.01% 4994
2014
Q4 		$85K Sell
8,400
-5,000
-37% -$25.3K ﹤0.01% 6002
2014
Q3 		$61K Sell
13,400
-25,333
-65% -$136K ﹤0.01% 6377
2014
Q2 		$261K Buy
38,733
+3,733
+11% +$28.1K ﹤0.01% 5301
2014
Q1 		$449K Sell
35,000
-22,138
-39% -$245K ﹤0.01% 4705
2013
Q4 		$463K Buy
+57,138
New +$503K ﹤0.01% 4832

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Bank of America's SRNE Position: Q1 2023 in Review

Bank of America sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 2,987,772 shares — an estimated $2.65M sold.

Bank of America first reported a position in SRNE in Q4 2013 and held it in 36 quarters. The position peaked at $3.48M in Q1 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Bank of America reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 2,987,772 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $2.65M.
  • Bank of America first reported a position in Sorrento Therapeutics, Inc. in Q4 2013 and held it in 36 quarters.
  • Bank of America's Sorrento Therapeutics, Inc. position peaked at $3.48M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.